![Nucleic acid therapies for CNS diseases: Pathophysiology, targets, barriers, and delivery strategies - ScienceDirect Nucleic acid therapies for CNS diseases: Pathophysiology, targets, barriers, and delivery strategies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168365922006885-ga1.jpg)
Nucleic acid therapies for CNS diseases: Pathophysiology, targets, barriers, and delivery strategies - ScienceDirect
![A brief survey on the application of metal-catalyzed azide–alkyne cycloaddition reactions to the synthesis of ferrocenyl-x-1,2,3-triazolyl-R (x = none or a linker and R = organic entity) compounds with anticancer activity - A brief survey on the application of metal-catalyzed azide–alkyne cycloaddition reactions to the synthesis of ferrocenyl-x-1,2,3-triazolyl-R (x = none or a linker and R = organic entity) compounds with anticancer activity -](https://ars.els-cdn.com/content/image/1-s2.0-S0010854522005914-ga1.jpg)
A brief survey on the application of metal-catalyzed azide–alkyne cycloaddition reactions to the synthesis of ferrocenyl-x-1,2,3-triazolyl-R (x = none or a linker and R = organic entity) compounds with anticancer activity -
![Recent advancements in nanoparticle-mediated approaches for restoration of multiple sclerosis - ScienceDirect Recent advancements in nanoparticle-mediated approaches for restoration of multiple sclerosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168365922000839-gr1.jpg)
Recent advancements in nanoparticle-mediated approaches for restoration of multiple sclerosis - ScienceDirect
![Recent advancements in nanoparticle-mediated approaches for restoration of multiple sclerosis - ScienceDirect Recent advancements in nanoparticle-mediated approaches for restoration of multiple sclerosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168365922000839-gr2.jpg)